ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

What Does Stage 2 Meaningful Use Mean for Your Rheumatology Practice?

Staff  |  November 1, 2012

The Centers for Medicare and Medicaid Services (CMS) Stage 2 Meaningful Use rule will focus on using data collected for more advanced clinical processes

Filed under:EMRsFrom the CollegeInformation TechnologyLegislation & AdvocacyPractice SupportQuality Assurance/ImprovementResearch RheumTechnology Tagged with:AC&RAmerican College of Rheumatology (ACR)Centers for Medicare & Medicaid Services (CMS)electronic health recordMeaningful useMedicarePractice ManagementResearchrheumatologistTechnology

Rheumatology Professionals and Patient Advocates Take Their Stories to Capitol Hill

Staff  |  November 1, 2012

This year’s Advocates for Arthritis conference was the American College of Rheumatology’s largest and most successful fly-in to date

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:AC&RAdvocacyAdvocates for ArthritisAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)CongressLegislationPoliticsrheumatologistTechnology

The Future is Here: The Role of Nurse Practitioners in Rheumatology

Ann Kepler  |  November 1, 2012

Nurse practitioners’ specialized knowledge and skills help to create an interlocking network of rheumatology patients and medical professionals

Filed under:Career DevelopmentEducation & TrainingPractice SupportProfessional TopicsWorkforce Tagged with:axial spondyloarthritis (SpA)nurse practitionerOsteoarthritispatient carePractice ManagementRheumatoid arthritisSclerodermaSystemic lupus erythematosusTraining

Treat to Target: Rheumatoid Arthritis in Pregnant Patients

Eliza F. Chakravarty, MD, MS  |  October 1, 2012

A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiologicsdrugMethotrexatepatient carepregnancyRheumatoid arthritis

The ACR/ARHP Annual Meeting: Focus on Practice

Staff  |  October 1, 2012

Members of the American College of Rheumatology and Associate Rheumatology Health Professionals members can learn about strategies for managing and improving their clinical practice

Filed under:Billing/CodingEducation & TrainingFrom the CollegeLegislation & AdvocacyMeeting ReportsPractice SupportProfessional Topics Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)BillingCodingLegislationPractice ManagementTechnologywebsite

Maintenance of Remission in ANCA-Associated Vasculitis

Paul A. Monach, MD, PhD  |  September 5, 2012

Relapses are common, but difficult to predict and prevent.

Filed under:ConditionsResearch RheumVasculitis Tagged with:ANCA-Associated VasculitisdrugGlucocorticoidsgranulomatosis with polyangiitisMethotrexatepatient careResearchrheumatologistrituximabVasculitis

EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus

Thomas R. Collins  |  September 5, 2012

MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.

Filed under:ConditionsEULAR/OtherMeeting ReportsResearch RheumRheumatoid ArthritisSjögren’s Disease Tagged with:BiomarkersEULARInternationalmicroRNAmiRNApatient careResearchRheumatoid arthritisrheumatologistSjogren's

Why We Are Advocates

James R. O’Dell, MD  |  September 5, 2012

Rheumatology advocacy efforts are paying off in 2012.

Filed under:Legislation & AdvocacyPresident's PerspectiveProfessional TopicsResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)LegislationResearchrheumatologistSGRSimple Tasks

Join 125 Colleagues and Patients to Bring Rheumatology’s Message to Capitol Hill

Staff  |  September 5, 2012

Rheumatology professionals and patients attending the ACR’s Advocates for Arthritis conference will convene on Capitol Hill to speak with lawmakers about issues affecting the rheumatology community.

Filed under:From the CollegeLegislation & AdvocacyProfessional TopicsResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)LegislationMedicareResearchrheumatologistSimple Tasks

Drug Updates: Lorcaserin, Acetaminophen, and More

Michele B. Kaufman, PharmD, BCGP  |  September 5, 2012

information on new approvals and medication safety

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisRheumatoid Arthritis Tagged with:acetaminophenAnkylosing SpondylitisApprovalsBiologicsdrugFDAPipelinepsoriatic arthritisrituximabSafetySteroids

  • « Previous Page
  • 1
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 129
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences